Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Cell Imaging System

By Drug Discovery Trends Editor | August 11, 2008

innovatis Inc. Cellavistainnovatis Inc. introduces Cellavista, an image-based system that can be used for rapid visualization of a broad range of cellular assays, while performing image analysis simultaneously. Combining brightfield and fluorescence optic capabilities, Cellavista enables users to acquire and analyze images for a wide array of cell-based assays, including, but not limited to, single cell cloning, cell confluence, suspension cell count, FACS seeding efficiency control, cell nuclei count and characterization, transfection efficiency, microplate quality control, viral plaque assays, fluorescent protein expression, and apoptosis assays.

Assay-specific analysis algorithms have been fully developed to identify cell clusters or colonies and are applicable to stem cell research. Using a graphical user interface, researchers can view a whole plate, zoom in on specific wells or colonies of interest, and view histograms, scatter plots, and time charts. Cellavista works with microplates, microscope slides, chamber slides, and culture dishes. Automated, image-stitching capabilities enable complete whole-well analysis as one image.

www.innovatis.com/cellavista

This article was published in Drug Discovery & Development magazine: Vol. 11, No. 8, August, 2008, pp. 9.


Filed Under: Drug Discovery

 

Related Articles Read More >

TransCelerate CEO Janice Chang wants trials to become part of routine care
STEERLife’s FragMelt platform manufactures drugs with heat sensitive active ingredient 
S&P report highlights Big Pharma’s concentration risk amid pre-JPM deal flurry
Eli Lilly in the Drug Discovery & Development Pharma 50
Lilly Phase 3b trial shows roughly 40-fold higher combined arthritis and weight-loss response
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2026 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE